Literature DB >> 11029244

Immunosuppressive therapy is valuable in aggressive multiple sclerosis.

T J Kilpatrick1, H Butzkueven.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11029244     DOI: 10.1054/jocn.2000.0789

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


× No keyword cloud information.
  1 in total

Review 1.  Escalation vs. Early Intense Therapy in Multiple Sclerosis.

Authors:  Bonaventura Casanova; Carlos Quintanilla-Bordás; Francisco Gascón
Journal:  J Pers Med       Date:  2022-01-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.